United States - English - NLM (National Library of Medicine)

bryant ranch prepack - promethazine hydrochloride (unii: r61zeh7i1i) (promethazine - unii:ff28ejq494) - promethazine hydrochloride 6.25 mg in 5 ml

United States - English - NLM (National Library of Medicine)

par pharmaceutical - codeine phosphate (unii: gsl05y1mn6) (codeine anhydrous - unii:ux6owy2v7j), promethazine hydrochloride (unii: r61zeh7i1i) (promethazine - unii:ff28ejq494), phenylephrine hydrochloride (unii: 04ja59tnsj) (phenylephrine - unii:1ws297w6mv) - codeine phosphate 10 mg in 5 ml - promethazine vc with codeine oral solution is indicated for the temporary relief of coughs and upper respiratory symptoms, including nasal congestion, associated with allergy or the common cold in patients 18 years of age and older. important limitations of use - not indicated for pediatric patients under 18 years of age [see use in specific populations (8.4) ]. - contraindicated in pediatric patients under 12 years of age [see contraindications (4) and use in specific populations (8.4) ]. - contraindicated in pediatric patients 12 to 18 years of age after tonsillectomy or adenoidectomy [see contraindications (4) and use in specific populations (8.4) ]. - because of the risks of addiction, abuse, and misuse with opioids, even at recommended doses [see warnings and precautions (5.1) ], reserve promethazine vc with codeine oral solution for use in adult patients for whom the benefits of cough suppression are expected to outweigh the risks, and in whom an adequate assessment of the etiology of the cough h

United States - English - NLM (National Library of Medicine)

par pharmaceutical - promethazine hydrochloride (unii: r61zeh7i1i) (promethazine - unii:ff28ejq494), phenylephrine hydrochloride (unii: 04ja59tnsj) (phenylephrine - unii:1ws297w6mv) - promethazine hydrochloride 6.25 mg in 5 ml - promethazine and phenylephrine hydrochloride oral solution is indicated for the temporary relief of upper respiratory symptoms, including nasal congestion, associated with allergy or the common cold. promethazine is contraindicated in comatose states, and in individuals known to be hypersensitive or to have had an idiosyncratic reaction to promethazine or to other phenothiazines. antihistamines are contraindicated for use in the treatment of lower respiratory tract symptoms, including asthma. phenylephrine is contraindicated in patients with hypertension or with peripheral vascular insufficiency (ischemia may result with risk of gangrene or thrombosis of compromised vascular beds). phenylephrine should not be used in patients known to be hypersensitive to the drug or in those receiving a monoamine oxidase inhibitor (maoi).

United States - English - NLM (National Library of Medicine)

cardinal health - midodrine hydrochloride (unii: 59jv96ytxv) (midodrine - unii:6ye7pbm15h) - midodrine hydrochloride 2.5 mg - midodrine hydrochloride tablets usp are indicated for the treatment of symptomatic orthostatic hypotension (oh). because midodrine hydrochloride tablets usp can cause marked elevation of supine blood pressure (bp>200 mmhg systolic), it should be used in patients whose lives are considerably impaired despite standard clinical care, including non-pharmacologic treatment (such as support stockings), fluid expansion and lifestyle alterations. the indication is based on midodrine hydrochloride tablet usp's effect on increases in 1-minute standing systolic blood pressure, a surrogate marker considered likely to correspond to a clinical benefit. at present, however, clinical benefits of midodrine hydrochloride tablets, principally improved ability to perform life activities, have not been established. further clinical trials are underway to verify and describe the clinical benefits of midodrine hydrochloride tablets usp. after initiation of treatment, midodrine hydrochloride tablets usp should be continued only for

Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

glaxosmithkline pharmaceutical sdn. bhd. - cetirizine dihydrochloride; pseudoephedrine hydrochloride -

New Zealand - English - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - ephedrine hydrochloride 3 mg/ml - solution for injection - 30 mg/10ml - active: ephedrine hydrochloride 3 mg/ml excipient: citric acid sodium chloride sodium citrate water for injection - indicated for the treatment of hypotension secondary to spinal anaesthesia.

Kenya - English - Pharmacy and Poisons Board

indoco remedies limited indoco remedies limited 166 cst road mumbai india - phenylpropanolaminehydrochloride bpparacetamol bp… - syrup - phenylpropanolamine hydrochloride bp… - nasal decongestants for systemic use:

Ireland - English - HPRA (Health Products Regulatory Authority)

alfasan nederland b.v - phenylpropanolamine hydrochloride - oral solution - phenylpropanolamin

United Kingdom - English - VMD (Veterinary Medicines Directorate)

alfasan nederland b.v. - phenylpropanolamine hydrochloride - oral solution - neurological agent - dogs

United Kingdom - English - VMD (Veterinary Medicines Directorate)

alfasan nederland b.v. - phenylpropanolamine hydrochloride - oral solution - neurological agent - dogs